<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.diabesityrounds.com/a/type-1-diabetes-linked-to-higher-mortality-with-a-larger-relative-gap-in-females</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-15T20:17:09.874Z</news:publication_date><news:title>Type 1 diabetes linked to higher mortality, with a larger relative gap in females</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/indian-moderate-carbohydrate-diet-plus-exercise-60-9-estimated-remission-in-earl</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-15T20:02:19.506Z</news:publication_date><news:title>Indian moderate-carbohydrate diet plus exercise: 60.9% estimated remission in early T2D</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/cdsco-expert-committee-no-phase-iii-waiver-for-alkem-semaglutide</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-15T02:20:21.652Z</news:publication_date><news:title>CDSCO expert committee: no Phase III waiver for Alkem semaglutide</news:title></news:news></url><url><loc>https://www.diabesityrounds.com/a/tirzepatide-lowered-hscrp-and-nt-probnp-in-a-meta-analysis-of-seven-studies</loc><news:news><news:publication><news:name>Diabesity Rounds</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-14T20:03:59.849Z</news:publication_date><news:title>Tirzepatide lowered hsCRP and NT-proBNP in a meta-analysis of seven studies</news:title></news:news></url></urlset>